Squarepoint
TNDM icon

Squarepoint’s Tandem Diabetes Care TNDM Stock Holding History

Squarepoint’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,500
Closed -$234K – 5417
2024
Q4 		$234K Buy
+6,500
New +$220K ﹤0.01% 4350
2023
Q2 		– Sell
-14,000
Closed -$569K – 4017
2023
Q1 		$569K Sell
14,000
-10,900
-44% -$451K ﹤0.01% 2229
2022
Q4 		$1.12M Buy
+24,900
New +$1.13M ﹤0.01% 1746
2022
Q3 		– Sell
-29,700
Closed -$1.76M – 3441
2022
Q2 		$1.76M Buy
+29,700
New +$2.44M 0.01% 1280

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's TNDM Position: Q3 2025 in Review

Squarepoint sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 180,660 shares — an estimated $3.37M sold.

Squarepoint first reported a position in TNDM in Q2 2017 and held it in 27 quarters. The position peaked at $21.2M in Q2 2022. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Squarepoint reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 180,660 Tandem Diabetes Care shares in Q3 2025, an estimated $3.37M.
  • Squarepoint first reported a position in Tandem Diabetes Care in Q2 2017 and held it in 27 quarters.
  • Squarepoint's Tandem Diabetes Care position peaked at $21.2M in Q2 2022.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.